MARIJANE HYNES: Open Payments
NPI 1043380850 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $45 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $95 |
| ABBVIE INC. | 3 | $70 |
| Lilly USA, LLC | 2 | $42 |
| PFIZER INC. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
Products named: UBRELVY, Ozempic, Wegovy, PREVNAR 20, CAPVAXIVE, MOUNJARO, TZIELD, QULIPTA.
Industry payments across DC — which companies pay providers there.
